EA199800146A1 - USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER - Google Patents
USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBERInfo
- Publication number
- EA199800146A1 EA199800146A1 EA199800146A EA199800146A EA199800146A1 EA 199800146 A1 EA199800146 A1 EA 199800146A1 EA 199800146 A EA199800146 A EA 199800146A EA 199800146 A EA199800146 A EA 199800146A EA 199800146 A1 EA199800146 A1 EA 199800146A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical compositions
- ippriflavon
- reduce
- cell number
- isoflavone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Настоящее изобретение относится к фармацевтическим композициям, которые могут использоваться для понижения числа CD8+ клеток, содержащим в качестве активного ингредиента 7-изопропоксиизофлавон в смеси с подходящими инертными, твердыми или жидкими носителями и, выборочно, с обычными терапевтическими добавками и вспомогательными агентами. Фармацевтические композиции в соответствии с изобретением готовят известными способами, и они являются подходящими для лечения человека или животных, находящихся в состоянии, когда желательна селективная супрессия CD8+ лимфоцитов.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to pharmaceutical compositions that can be used to lower the number of CD8 + cells, containing 7-isopropoxy-isoflavone as an active ingredient in a mixture with suitable inert, solid or liquid carriers and, optionally, with conventional therapeutic additives and auxiliary agents. Pharmaceutical compositions in accordance with the invention are prepared by known methods, and they are suitable for treating humans or animals in a state where selective suppression of CD8 + lymphocytes is desired. The international application was published along with an international search report.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
PCT/HU1996/000038 WO1997003664A1 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Publications (1)
Publication Number | Publication Date |
---|---|
EA199800146A1 true EA199800146A1 (en) | 1998-08-27 |
Family
ID=10987063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199800146A EA199800146A1 (en) | 1995-07-21 | 1996-07-16 | USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0841915A1 (en) |
JP (1) | JP2001503371A (en) |
KR (1) | KR19990028933A (en) |
CN (1) | CN1191483A (en) |
AR (1) | AR002905A1 (en) |
AU (1) | AU6367096A (en) |
BG (1) | BG102182A (en) |
BR (1) | BR9610187A (en) |
CA (1) | CA2227421A1 (en) |
CZ (1) | CZ2798A3 (en) |
EA (1) | EA199800146A1 (en) |
EE (1) | EE9800020A (en) |
HR (1) | HRP960345A2 (en) |
HU (1) | HU9502198D0 (en) |
IL (1) | IL122751A0 (en) |
MX (1) | MX9800603A (en) |
NO (1) | NO980127D0 (en) |
PL (1) | PL324460A1 (en) |
SK (1) | SK3298A3 (en) |
WO (1) | WO1997003664A1 (en) |
YU (1) | YU42796A (en) |
ZA (1) | ZA966079B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1241079B (en) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE |
HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/en unknown
-
1996
- 1996-07-16 EA EA199800146A patent/EA199800146A1/en unknown
- 1996-07-16 CN CN96195722A patent/CN1191483A/en active Pending
- 1996-07-16 IL IL12275196A patent/IL122751A0/en unknown
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/en unknown
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/en not_active Application Discontinuation
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 MX MX9800603A patent/MX9800603A/en unknown
- 1996-07-16 JP JP50646497A patent/JP2001503371A/en active Pending
- 1996-07-16 PL PL96324460A patent/PL324460A1/en unknown
- 1996-07-16 EE EE9800020A patent/EE9800020A/en unknown
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 BR BR9610187A patent/BR9610187A/en not_active Application Discontinuation
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 SK SK32-98A patent/SK3298A3/en unknown
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/en unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/en not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/en unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/en unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127D0/en unknown
- 1998-01-14 BG BG102182A patent/BG102182A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR002905A1 (en) | 1998-04-29 |
EE9800020A (en) | 1998-08-17 |
SK3298A3 (en) | 1998-07-08 |
KR19990028933A (en) | 1999-04-15 |
AU6367096A (en) | 1997-02-18 |
EP0841915A1 (en) | 1998-05-20 |
CZ2798A3 (en) | 1998-06-17 |
CA2227421A1 (en) | 1997-02-06 |
MX9800603A (en) | 1998-04-30 |
BG102182A (en) | 1998-08-31 |
IL122751A0 (en) | 1998-08-16 |
NO980127L (en) | 1998-01-12 |
JP2001503371A (en) | 2001-03-13 |
HU9502198D0 (en) | 1995-09-28 |
PL324460A1 (en) | 1998-05-25 |
ZA966079B (en) | 1998-01-19 |
BR9610187A (en) | 1998-07-28 |
YU42796A (en) | 1999-03-04 |
WO1997003664A1 (en) | 1997-02-06 |
NO980127D0 (en) | 1998-01-12 |
HRP960345A2 (en) | 1998-02-28 |
CN1191483A (en) | 1998-08-26 |
WO1997003664A8 (en) | 1999-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8702907D0 (en) | STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTE COLONY STIMULATING FACTOR AND PROCESS FOR PRODUCING THE SAME | |
EA200100103A1 (en) | CELL ADHESION INHIBITORS | |
EA199800943A1 (en) | UREA DERIVATIVES AND THEIR USE AS INHIBITORS INOSINE-5`-MONO-PHOSPHATE-DEHYDROGENASE INHIBITORS | |
IL74535A (en) | Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof | |
DK0735890T3 (en) | Mixtures of 2 ', 3'-dideoxyinosine and hydroxycarbamide to inhibit retroviral spread | |
KR900018098A (en) | Pyridone Carboxylic Acids and Antibacterials | |
TW282393B (en) | ||
RU94041836A (en) | Derivatives of amidine, mixture of their isomers or individual isomers and their salts, pharmaceutical composition exhibiting antagonistic activity with respect to leukotriene b4 activity | |
ATE215827T1 (en) | IMMUNOLOGICAL ACTIVITY OF RHAMNOLIPIDS | |
ZA83628B (en) | Pharmacologically active pyrazolo/4,3-/pyridines | |
DE3862337D1 (en) | PHARMACEUTICAL PREPARATIONS CONTAINING ESTER OR AMIDE AS ACTIVE INGREDIENTS. | |
DE3172298D1 (en) | Pharmaceutical compositions | |
EA199900876A1 (en) | PHARMACEUTICAL COMPOSITIONS AGAINST COUGH | |
IE861623L (en) | Biologically active copolymer composition | |
MD1688F2 (en) | Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection | |
ES2134237T3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLICO ACID. | |
ES2002083A6 (en) | Pyroglutamide derivatives | |
BE887566A (en) | NOVEL 2-AMINO-3- (ALPHA-HEDROXYBENZYL) -PHENYLACETICS AND THEIR ESTERS AND AMIDES, ESPECIALLY USEFUL AS ANTI-INFLAMMATORY AGENTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
FR2420344A1 (en) | NEW OXIME-ETHERS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. | |
EA199800146A1 (en) | USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER | |
KR880007068A (en) | Use of 13-cis retinoic acid | |
KR850700108A (en) | Anti-tumor pharmaceutical composition and preparation method thereof | |
ES8406468A1 (en) | Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them. | |
FR2384791A1 (en) | NEW EVERNINOMICINE DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAID DERIVATIVES | |
DK381983A (en) | METHOD FOR PREPARING SPIRO (2H-1,4-BENZODIOXEPIN-3 (5H) 4'-PIPERIDINE AND -3'-PYRROLIDE COMPOUNDS) |